Federal and state regulators have filed a series of enforcement actions against companies that sold discount medical cards to consumers who believed they were buying real health insurance. The Federal Trade Commission sued a telemarketing operation in April 2026 for allegedly pitching “state issued” PPO plans with no deductible and low copays, when the products were actually bundles of medical discounts and ancillary services. Combined penalties and settlements across federal and state cases now exceed $310 million, and the pattern keeps repeating: aggressive phone and online pitches target people actively shopping for coverage, collect monthly payments, and deliver products that leave buyers responsible for nearly all of their medical bills.
How discount cards get sold as real insurance
The mechanics of these schemes follow a consistent script. A consumer searches online for health coverage or responds to a telemarketing call. The seller describes what sounds like a traditional insurance plan, complete with references to PPO networks, low copays, and broad benefits. The buyer pays a monthly fee and receives a card. Only after visiting a doctor or hospital does the buyer discover the card offers modest discounts on certain services rather than the coverage promised during the sale.
The FTC’s April 2026 complaint lays out exactly how one operation ran this playbook. According to the agency, telemarketers told consumers they would receive “state issued” PPO insurance with no deductible and low copays. What buyers actually got were products that were neither PPO plans nor anything resembling the health insurance described on the call. The gap between the sales pitch and the delivered product is the core of every case regulators have brought.
The problem extends beyond individual boiler rooms. Lead-generation platforms that connect insurance shoppers with agents and brokers have also faced scrutiny. Per the FTC, Assurance IQ and MediaAlpha agreed to pay a total of $145 million to settle charges that they misled consumers seeking health insurance. That case exposed how the digital pipeline works: consumers enter personal information on comparison sites, and their leads get routed to sellers who may push limited-benefit products or discount plans instead of genuine coverage.
In practice, this means a consumer might think they are comparing Affordable Care Act plans or employer-style coverage, when in reality their contact details are being sold to third-party marketers. Those marketers, often operating from call centers, can then steer the conversation away from regulated major medical policies and toward loosely regulated discount products. Because the initial website looks legitimate and may reference well-known insurers, many buyers assume that any follow-up offer must be real insurance too.
State crackdowns from California to Massachusetts
Federal action alone has not contained the problem, and state attorneys general have pursued their own cases with strikingly large penalties. California Attorney General Rob Bonta announced a $1.3 million settlement against companies that the state said operated sham health insurance plans. The California investigation found that the companies collected mandatory monthly payments in exchange for payment of medical services, yet the products did not provide essential health benefits required of licensed insurance.
Massachusetts has been even more aggressive. Per the state attorney general’s office, a superior court ordered health insurance companies to pay over $165 million for a deceptive sales scheme that cheated consumers. The state also filed a separate complaint against HealthMarkets and related entities, according to court documents, alleging deceptive marketing and sale of health coverage products that included discount health plans bundled with or substituted for major medical insurance.
These state-level cases test an interesting pattern. Enforcement actions have clustered in states with stricter insurance marketing rules, such as California and Massachusetts. Both states require detailed disclosures and tightly regulate what can be marketed as health coverage. That raises a question about whether sellers deliberately shift operations to states with lighter oversight rather than redesigning their products. The available enforcement record does not yet confirm that migration pattern with hard data, but the geographic concentration of large penalties is notable.
State regulators also highlight the real-world impact behind the numbers. In complaints and press releases, they describe consumers who delayed care, incurred large hospital bills, or faced collections after discovering that their “plan” paid little or nothing. Many victims were self-employed, between jobs, or otherwise outside employer-sponsored coverage, making them especially vulnerable to pitches that promised comprehensive protection at a fraction of typical premiums.
Why discount cards fall through regulatory gaps
One reason these schemes persist is that discount health plans and cards occupy a gray zone. Per guidance from the Commonwealth of Massachusetts, discount health plans and cards are not regulated by Massachusetts or federal law. That creates tension with the enforcement actions brought by the same state. Massachusetts has pursued sellers for deceptive marketing, but the underlying discount products themselves sit outside the insurance regulatory framework. The state’s own consumer materials are blunt: people are warned not to buy a discount health plan or card as an alternative to health insurance.
The FTC’s consumer advice division has echoed that warning. According to the agency’s guidance, dishonest marketers may make it seem like they are selling health insurance when it is really a discount plan. Red flags include sellers who will not provide written details about benefits and limitations before taking payment, and products described with vague terms that mimic insurance jargon without meeting the legal definition of coverage.
This regulatory gap means that the products themselves are often legal to sell. What triggers enforcement is the way they are marketed. When a telemarketer claims that a discount card is “just like” major medical coverage, or suggests it meets legal coverage requirements when it does not, regulators can pursue the seller for deception. But if the same product is clearly described as a voluntary discount program that merely reduces the price of some services, it may fall outside the reach of insurance law.
That distinction can be hard for consumers to parse in a high-pressure sales call. Many buyers do not know the difference between insurance, which shifts financial risk to a licensed carrier, and discount arrangements, which only negotiate lower prices. Marketers exploit that confusion by emphasizing familiar terms like “copay” and “network,” while downplaying or obscuring the fact that there is no obligation for the program to pay medical claims.
What consumers can do to protect themselves
Regulators consistently urge consumers to slow down and verify any offer before handing over payment information. One basic step is to ask for written plan documents that spell out what is covered, what is not, and who pays what portion of medical bills. Legitimate health insurance will identify a licensed insurer, list covered services, and explain deductibles, coinsurance, and out-of-pocket maximums. Discount cards, by contrast, typically promise only percentage reductions from “retail” prices and do not guarantee payment of claims.
Consumers can also contact their state insurance department to confirm whether a company is licensed to sell health insurance where they live. If a salesperson refuses to provide a legal company name, discourages independent verification, or pressures the consumer to sign up “today only,” regulators say those are strong signals to walk away. People shopping online should be cautious about entering phone numbers and email addresses on comparison sites without checking who actually operates the site and how their information will be used.
For those who already bought a discount product they believed was insurance, agencies recommend filing complaints with both the FTC and the state attorney general. Past enforcement actions have sometimes led to restitution funds or refunds for affected consumers, particularly in large, multi-state cases. Even when money cannot be recovered, complaints help regulators identify patterns and build cases against repeat offenders.
The wave of recent crackdowns suggests that regulators are increasingly willing to treat deceptive discount card sales as a serious consumer protection problem rather than a niche annoyance. Yet as long as discount plans remain lightly regulated and consumers struggle to distinguish them from real insurance, enforcement will likely remain reactive-chasing schemes after the damage is done. For now, the most reliable defense is a skeptical eye, careful verification, and a clear understanding that if an offer sounds like full-coverage health insurance at a deep discount, it may turn out to be little more than a card and a promise.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
